Open Label Prostate Cancer Study

NCT01162395 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: AZD3514

Sponsor

AstraZeneca